Crossmark

STING agonist-based treatment promotes vascular normalization and tertiary lymphoid structure formation in the therapeutic melanoma microenvironment

Crossref DOI link: https://doi.org/10.1136/jitc-2020-001906

Published Online: 2021-02-01

Published Print: 2021-02

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Chelvanambi, Manoj https://orcid.org/0000-0003-2130-3118
Fecek, Ronald J

Taylor, Jennifer L

Storkus, Walter J https://orcid.org/0000-0001-8961-4444
Funding

Funding for this research was provided by:

Center for Scientific Review (NIH CA169118)

Center for Scientific Review (NIH CA204419)

Center for Scientific Review (NIH CA234212)
License Information

License valid from 2021-02-01